Search results
Jan 13, 2023 · Jan 13, 2023,06:00am EST. In an exclusive excerpt from For Blood And Money, the untold story of Wayne Rothbaum and the worst trade of his life. But what cost him some $700 million turned out to be ...
Feb 13, 2023 · In the end, Bob Duggan made $3.5 billion selling Pharmacyclics to AbbVie, and Wayne Rothbaum made $3 billion selling Acerta to AstraZeneca. Is that really the incentive we need to develop new ...
People also ask
Who is David Rothbaum?
What cost Wayne Rothbaum $700 million?
How much did Wayne Rothbaum cost a cancer patient?
Who is Wayne Rothbaum?
Jan 10, 2023 · A gripping business narrative and scientific thriller about what it takes to bring a wonder drug to market―and save countless lives. For Blood and Money tells the little-known story of how an upstart biotechnology company created a one-in-a-million cancer drug, and how members of the core team―denied their share of the profits―went and did it again.
- (1.5K)
- Hardcover
Jan 30, 2023 · Vardi spends much of the book detailing how Wayne Rothbaum, a savvy micromanaging stock trader and early investor in Pharmacyclics, influences the company’s direction, including key scientific ...
- Heidi Ledford
Mr. Rothbaum is the President and Founder of Quogue Capital LLC, a life sciences investment fund he founded in 2001. Beginning in 2012, Mr. Rothbaum served as the co-founder and largest investor of Acerta Pharma, B.V., a Dutch biotech focused on developing selective, covalent small molecules to treat cancer and inflammation.
Dec 11, 2022 · Notably, that recent purchase by Wayne Rothbaum is the biggest insider purchase of Iovance Biotherapeutics shares that we've seen in the last year. So it's clear an insider wanted to buy, at ...
